Bioasis is dedicated to delivering hope to patients suffering with neurological diseases and disorders. Our breakthrough science focuses on transporting medicines across the blood-brain barrier, providing a path to hundreds of previously untreatable diseases of the central nervous system.
The Company also launches new website bioasis.us
biOasis Appoints Christopher P. Lowe, M.B.A. as Chief Financial Officer and Board AdvisorOct 2, 2017
Lowe brings extensive experience serving as an executive and board member for early, research-stage biotechnology companies
The Company welcomes new board members Dr. Nancy Stagliano, Dr. Deborah Rathjen and Dr. Maha Radhakrishnan